SCHEMBL1833251

SCHEMBL1833251

O=C(O)Oc1cc2ccccc2[nH]1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.55
▸ DAO P14920 2/20 0.55
▸ MAPT P10636 1/20 0.55
▸ HPGD P15428 1/20 0.55
▸ SRD5A2 P31213 1/20 0.55
▸ HSD17B10 Q99714 1/20 0.55
▸ FLT3 P36888 3/20 0.52
▸ LMNA P02545 2/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ IDO1 P14902 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ DDO Q99489 1/20 0.46
▸ TP53 P04637 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ PDGFRB P09619 3/20 0.44
▸ PDGFRA P16234 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10441468 0.84 PDGFRB (0.58) KDM4EDAOMAPTHPGDSRD5A2
SCHEMBL3836490 0.84 FLT3 (0.50) KDM4EDAOMAPTHPGDSRD5A2
SCHEMBL9378872 0.84 FLT3 (0.50) KDM4EDAOMAPTHPGDSRD5A2
SCHEMBL4265956 0.84 PDGFRB (0.56) KDM4EDAOMAPTHPGDSRD5A2
SCHEMBL30073611 0.84 PDGFRB (0.56) KDM4EDAOMAPTHPGDSRD5A2
SCHEMBL6586200 0.82 KDM4E (0.50) KDM4EDAOMAPTHPGDSRD5A2
SCHEMBL6470774 0.81 FLT3 (0.47) KDM4EDAOMAPTHPGDSRD5A2
SCHEMBL31561461 0.81 FLT3 (0.61) KDM4EDAOMAPTHPGDSRD5A2
SCHEMBL10343383 0.81 FLT3 (0.47) KDM4EDAOMAPTHPGDSRD5A2
SCHEMBL29020309 0.80 IDO1 (0.57) KDM4EDAOMAPTHPGDSRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2968272-B1 USE OF INDOLE COMPOUNDS FOR FAT REDUCTION AND SKIN AND SOFT TISSUE TIGHTENING ALEVERE MEDICAL CORP (US) 2021-06-16 — — EP claimed
CN-110372566-B Method for catalyzing rearrangement of indole carbonate by chiral 3, 4-diaminopyridine nitrogen-oxygen catalyst 河南师范大学 2020-08-04 — — CN claimed
EP-2948454-B1 TRIAZINE COMPOUNDS AND A PROCESS FOR PREPARATION THEREOF COUNCIL OF SCIENT & IND RES AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGISTRATION OF SOCIETI (IN) 2017-05-31 — — EP claimed
EP-1970470-B1 Chrome(VI)-free black passivates for surfaces containing zinc ATOTECH DEUTSCHLAND GMBH (DE) 2011-05-11 — — EP claimed
WO-2010026096-A1 7-(PIPERAZINE-1-YMETHYL)-1H-INDOLE-2-CARBOXYLIC ACID (PHENYL)-AMIDE DERIVATIVES AND ALLIED COMPOUNDS AS P38 MAP KINASE INHIBITORS FOR THE TREATMENT OF RESPIRATORY DISEASES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-03-11 — — WO claimed
EP-2149551-A1 N-(indol-3-ylalkyl)-(hetero)arylamid derivatives as modulators of EP2 receptors Bayer Schering Pharma AG (DE) 2010-02-03 — — EP claimed
EP-1970470-A1 Chrome(VI)-free black passivates for surfaces containing zinc ATOTECH DEUTSCHLAND GMBH (DE) 2008-09-17 — — EP claimed
WO-2008107039-A1 CHROMIUM(VI)-FREE BLACK PASSIVATION OF SURFACES CONTAINING ZINC ATOTECH DEUTSCHLAND GMBH (DE) 2008-09-12 — — WO claimed
EP-0868535-B9 METHODS AND COMPOSITIONS FOR DETERMINING THE SEQUENCE OF NUCLEIC ACID MOLECULES QIAGEN GENOMICS INC (US) 2007-05-09 — — EP claimed
EP-1689711-A1 METHOD FOR PRODUCING N- 1-(S)-CARBALKOXY-3-PHENYLPROPYL|-S-ALANYL-2S, 3AR, 7AS-OCTAHYDROINDOL-2-CARBOXYLIC ACID COMPOUNDS Azad Pharmaceutical Ingredients AG (CH) 2006-08-16 — — EP claimed
EP-0743574-B1 Migration imaging members XEROX CORP (US) 2000-12-27 — — EP claimed
EP-0743573-B1 Method for obtaining image contrast migration imaging members XEROX CORP (US) 2000-09-06 — — EP claimed
EP-0673782-B1 Recording sheets containing pyrrole, pyrrolidine, pyridine, piperidine, homopiperidine, quinoline, isoquinoline, quinuclidine, indole, and indazole compounds XEROX CORP (US) 2000-06-14 — — EP claimed
EP-0868535-B1 METHODS AND COMPOSITIONS FOR DETERMINING THE SEQUENCE OF NUCLEIC ACID MOLECULES RAPIGENE INC (US) 2000-04-12 — — EP claimed
EP-0519971-B1 NOVEL PHARMACEUTICALLY ACTIVE COMPOUNDS WHICH CAN BE FORMED FROM 1,3,4,6,7,8-HEXAHYDRO-2H-PYRIMIDO-(1,2-a)-PYRIMIDINE INST SOZIAL MED FORSCHUNG SA (CH) 1997-01-15 — — EP claimed
EP-0526708-A1 Sulfonamide, preparation and use thereof as medicine and intermediate F. HOFFMANN-LA ROCHE AG (CH) 1993-02-10 — — EP claimed
EP-0308339-B1 PROCESS FOR THE INDUSTRIAL PREPARATION OF PERHYDROINDOLE -2(2S,3AS,7AS)-CARBOXYLIC ACID, USE IN THE PREPARATION OF CARBOXYALKYL DIPEPTIDES ADIR ET COMPAGNIE (FR) 1992-05-06 — — EP claimed
EP-0308341-B1 PROCESS FOR THE INDUSTRIAL SYNTHESIS OF PERINDOPRIL AND FOR ITS PRINCIPAL SYNTHESIS INTERMEDIATES ADIR ET COMPAGNIE (FR) 1990-12-12 — — EP claimed
EP-0117447-A1 Cyclic peptides with somatostatin activity HOECHST AKTIENGESELLSCHAFT (DE) 1984-09-05 — — EP claimed
EP-0043752-B1 PYRANOINDOLE DERIVATIVE AND PROCESS FOR ITS PREPARATION SOCIETE DE RECHERCHES INDUSTRIELLES S.O.R.I. Société anonyme dite: (FR) 1984-06-13 — — EP claimed
Send feedback